Symmetry Partners, LLC Exact Sciences Corp Transaction History

Symmetry Partners, LLC

  • $422 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 02, 2024
BUY
$59.06 - $75.72 $176,825 - $226,705
2,994 New
2,994 $227,000
Q3 2021

Oct 18, 2021
SELL
$90.24 - $124.05 $184,360 - $253,434
-2,043 Closed
0 $0
Q3 2020

Nov 03, 2020
BUY
$72.92 - $102.01 $148,975 - $208,406
2,043 New
2,043 $208,000
Q4 2019

Feb 12, 2020
SELL
$77.66 - $99.74 $216,438 - $277,975
-2,787 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$89.51 - $118.04 $249,464 - $328,977
2,787 New
2,787 $329,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Symmetry Partners, LLC Portfolio

Follow Symmetry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email